Sector: MedicalAtheroGenics, Inc. (NASDAQ: AGIX)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 272 |
Technical : | 170 |
Performance : | 305 |
Overall: | 289 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 274 |
Technical : | 132 |
Performance : | 305 |
Overall: | 282 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 273 |
Technical : | 192 |
Performance : | 305 |
Overall: | 296 |
Number of Stocks: | 306 |
Headlines
- Analyst Comments: AGIX, Scientific Games, Sohu.com, Barclays, COSI, Cleveland-Cliffs,Potash Corp, Freddie Mac, OSI Pharma
Oct 08, 2008 08:44 AM | AGIX, ANR, BCS, CLF, COSI, FRE
- Analyst Comments: AtheroGenics, Toyota, Jamba, GlaxoSmithKline, Metabasis, AFLAC, Crown Castle, Epicor, Amylin Pharma, CNOOC, Skyworks, Tejon
Oct 02, 2008 08:33 AM | AFL, AGIX, AMLN, BBI, CAS, CCI
- Analyst Comments: AtheroGenics, ConocoPhillips, Carnival Corporation, Zions Bank, Chevron
Jun 12, 2008 10:34 AM | AGIX, CCL, COP, CVX, ECA, LUKOY
- Analyst Comments: Monarch Casino, Plexus, Crown Castle, Ctrip.com, AtheroGenix, Arch Coal, Logitech, McClatchy
Apr 25, 2008 12:50 PM | ACI, AGIX, CCI, CTRP, LOGI, MCRI
- Analyst Comments: ConEd, Sempra Energy, Hawaiian Electric, AK Steel Holding, CACI International, Magna International, AtheroGenics, Potash
Apr 14, 2008 08:49 PM | AGIX, AKS, CAI, ED, HE, MGA
- Analyst Comments: PepsiCo, Baidu, Penn Virginia, AtheroGenics, DIRECTV, Baker Hughes,
Feb 19, 2008 11:14 AM | AGIX, BHI, BIDU, DISH, DTV, LCAPA
- 2ND UPDATE: AstraZeneca To Buy MedImmune For $15.6 Billion
Apr 23, 2007 04:31 PM | AGIX, AZN, GSK, LLY, MEDI, MRK
- 2ND UPDATE: AstraZeneca To Buy MedImmune For $15.6 Billion
Apr 23, 2007 04:31 PM | AGIX, AZN, GSK, LLY, MEDI, MRK
- 3rd UPDATE: AtheroGenics Shares Down, AstraZeneca Exits Drug
Apr 23, 2007 01:04 PM | AGIX, AZN
- 2nd UPDATE: AtheroGenics Shares Down, AstraZeneca Exits Drug
Apr 23, 2007 11:59 AM | AGIX, AZN
- AtheroGenics Receives Delisting Notice From NASDAQ Global Market Due to Chapter 11 Filing
Oct 10, 2008 05:16 PM | AGIX
- Zacks Analyst Blog Highlights: Wipro, Ltd., Skechers USA, Inc., Coca- Cola Hellenic Bottling Co., Scientific Games Corp. And AtheroGenics, Inc.
Oct 08, 2008 12:21 AM | AGIX, CCH, SGMS, SKX, WIT
- AtheroGenics Files for Chapter 11 Bankruptcy
Oct 07, 2008 06:52 AM | AGIX
- Zacks Analyst Blog Highlights: Toyota Motor Corp., Jamba, Inc., AtheroGenics, Inc., Vodafone Group Plc. And Xilinx, Inc.
Oct 01, 2008 04:18 PM | AGIX, JMBA, TM, VOD, XLNX
- AtheroGenics Restructures Board of Directors
Sep 10, 2008 07:14 PM | AGIX
- AtheroGenics Seeks to Realign Capital Structure
Sep 02, 2008 08:40 AM | AGIX
- AtheroGenics Reports Second Quarter 2008 Financial Results
Aug 05, 2008 07:00 AM | AGIX
- BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRD
Aug 01, 2008 10:20 AM | AGIX, APKT, BIOS, CHRD, CNXT, NOVA
- AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
Jul 31, 2008 07:00 AM | AGIX
- AtheroGenics to Report Second Quarter 2008 Financial Results on August 5, 2008
Jul 25, 2008 07:15 AM | AGIX
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AGIX
|
Compare to S&P
|
| YTD |
-81.58 %
|
-67.77 %
|
| 4 Weeks |
-82.05 %
|
-78.66 %
|
| 12 Weeks |
-89.06 %
|
-86.26 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 5.26 %
|
|
EPS Growth in Last Year: -125.00 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -100.00 %
|
|
